Leadership

With more than 25 years of healthcare leadership experience, Ella serves as President, Network Operations for American Oncology Network (AON). In this role, she oversees practice operations, strategic growth initiatives, integrations, operational excellence and infrastructure development across the organization. Working closely with other members of the executive leadership team, she helps drive execution of the company’s strategic vision while supporting practice performance, physician engagement and the delivery of high-quality, patient-centered cancer care in communities across the country.

Prior to joining AON, Ella served as Regional Senior Vice President and previously Senior Vice President of Operations for The US Oncology Network, where she was a member of the senior leadership team responsible for operations management, strategic planning, physician recruitment, marketing and practice growth across multiple states. During her tenure, she held full P&L responsibility and played a key role in practice integrations, market expansion, operational restructuring and leadership development. She successfully led teams through periods of significant growth and change while improving financial performance, operational efficiency and patient access to care.

Ella joined The US Oncology Network in 2008 as Executive Director of Rocky Mountain Cancer Centers, one of the nation’s largest community oncology practices. In that role, she oversaw operations across multiple cancer centers and sites of care, leading initiatives that strengthened practice performance, enhanced physician productivity and supported continued organizational growth.

Before entering oncology, Ella served as Senior Vice President of Business Planning and Development for Gambro Healthcare, a global leader in renal care services. As part of the senior management team, she was responsible for strategic planning, payer strategy, acquisitions, marketing and growth initiatives. She helped lead significant operational and financial improvements that enhanced patient outcomes and contributed to the company’s successful acquisition by DaVita.

Ella earned a Bachelor of Arts in Biology from Boston University and a Master of Business Administration with concentrations in Finance and International Business from the Sawyer School of Management at Suffolk University. She also completed the Advanced Management Program in International Business at IESE Business School in Barcelona, Spain.

As medical director of radiation oncology, Dr. Berilgen provides clinical leadership for AON’s radiation oncology initiatives. In this role, he helps guide the development of clinical protocols, expand patient access to new, evidence-based therapies and support the advancement of radiation oncology across the network.

Dr. Berilgen currently practices and serves as head of radiation oncology and diagnostic imaging at Woodlands Cancer Institute. He also chairs the AON Radiation Oncology Committee and the radiation oncology segment of the Physician Leadership Committee, providing guidance and insight to the AON Board of Directors.

He earned his Doctor of Medicine from Baylor College of Medicine in Houston, where he completed clinical rotations at Houston Methodist Hospital and The University of Texas MD Anderson Cancer Center. Dr. Berilgen completed a residency in radiation oncology at The University of Texas Medical Branch School of Medicine in Galveston. During residency, he pursued additional elective training at MD Anderson Cancer Center, focusing on breast, gastrointestinal and lung malignancies. He also completed pediatric radiation oncology training at St. Jude Children’s Research Hospital in Memphis, Tennessee.

Throughout his training, Dr. Berilgen gained extensive experience in intensity-modulated radiation therapy, 3D conformal radiation therapy, CT-, MRI- and PET-based simulation, high-dose-rate brachytherapy for breast, prostate and gynecologic cancers, as well as respiratory gating and four-dimensional treatment planning.

Board-certified in radiation oncology by the American Board of Radiology, Dr. Berilgen specializes in image-guided radiotherapy, intensity-modulated radiotherapy, stereotactic body radiotherapy, stereotactic radiosurgery and volumetric modulated arc therapy.

Dr. Berilgen is a member of the American Brachytherapy Society (ABS), the American Radium Society (ARS), the American Society of Clinical Oncology (ASCO), the American Society for Radiation Oncology (ASTRO) and the Texas Medical Association (TMA).

Dr. Luis T. Campos is a Board-certified medical oncologist and Founder and President of Oncology Consultants, P.A. in Houston. With more than 45 years of experience in oncology, Dr. Campos is widely recognized for his leadership in clinical research and his commitment to advancing innovative cancer therapies.

Dr. Campos earned his medical degree from The Peruvian University Cayetano Heredia. He completed his residency at Graduate Hospital University, and went on to complete a fellowship in oncology at the University of Texas MD Anderson Cancer Center. He is Board-certified in internal medicine and medical oncology.

Throughout his distinguished career, Dr. Campos has served as a Principal Investigator or Sub-Investigator in more than 300 oncology clinical trials, including Phase I–IV studies across a broad spectrum of malignancies such as lung, breast, prostate, colon, pancreatic, and hepatocellular cancers.

In addition to his clinical and research work, Dr. Campos has held academic appointments at the University of Texas Medical School and remains actively involved in national professional organizations, including the American Society of Clinical Oncology and the American Medical Association. He continues to contribute to the advancement of oncology through research, publication, and clinical leadership.

As medical director of the Pharmacy and Therapeutics Committee, Dr. Mulherin plays a key role in the execution and implementation of AON’s clinical and medication-use policies. He is actively involved in longer-term strategic planning to ensure AON’s care models remain evidence-based, patient-centered and aligned with the evolving oncology landscape. His leadership supports consistent, high-quality treatment decisions across the network.

Dr. Mulherin also serves as a member of AON’s Value-Based Care Committee, where he contributes to initiatives focused on improving outcomes, enhancing care coordination and advancing sustainable, value-driven oncology care.

Dr. Mulherin received his medical degree from Loyola University Chicago and completed his internal medicine residency at the University of Wisconsin–Madison. He went on to complete a fellowship in hematology and oncology at Indiana University. He is Board certified in internal medicine, hematology and medical oncology and is a member of the American Medical Association, the American Society of Clinical Oncology and the American Society of Hematology.

As medical diversity director of research, Dr. Birhiray provides leadership and oversight for clinical research initiatives across the organization. In this role, he helps advance innovative treatment options, supports the development of evidence-based care pathways and expands patient access to emerging therapies through inclusive, community-focused clinical trials.

Dr. Birhiray currently practices at Hematology Oncology of Indiana. Prior to joining the practice, he was a medical oncologist at Marshfield Cancer Center in Marshfield, Wisconsin, where he also served as director of the bone marrow transplant program.

He earned his medical degree from the University of Benin in Nigeria and completed his internal medicine residency at Columbus Hospital, an affiliate of Northwestern University, in Chicago. He went on to complete a bone marrow transplant fellowship at Johns Hopkins University and a medical oncology fellowship at the National Cancer Institute in Bethesda, Maryland.

Dr. Birhiray has participated in numerous research initiatives and has published on immunotherapy, lymphomas and bone marrow transplantation. He is a member of the American Society of Clinical Oncology, the American Society of Hematology, the American Medical Association and the Wisconsin Medical Society.

As chair of the Pharmacy and Therapeutics Committee, Dr. Patel provides clinical leadership and oversight for AON’s medication management strategy. In this role, he guides evidence-based drug policies, evaluates emerging oncology therapies and ensures safe, effective and cost-conscious use of cancer treatments across the network. His work helps support consistent, high-quality care for patients throughout AON.

Dr. Patel also serves on the AON Advisory Board Executive Committee, representing Zangmeister Cancer Center in Columbus, Ohio.

He received his M.B.B.S. from Baroda Medical College at Maharaja Sayajirao University in Gujarat, India, where he completed his internship and a residency in pathology. He later worked as a research associate at the University of Illinois at Chicago before completing his internal medicine residency at Cook County Hospital in Chicago and his hematology/oncology fellowship at the University of Cincinnati. Dr. Patel is a diplomate of the American Board of Internal Medicine in medical oncology.

The author of numerous peer-reviewed publications, Dr. Patel is an active member of several professional organizations, including the Community Oncology Alliance, Columbus Medical Association, Ohio State Medical Association, Ohio Hematology Oncology Society and the American Society of Clinical Oncology.

As medical director of research, Dr. Boccia provides strategic leadership for AON’s clinical research initiatives. In this role, he helps expand patient access to innovative therapies, guides the development of evidence-based treatment protocols and supports the advancement of oncology research across the organization.

Dr. Boccia also represents The Center for Cancer and Blood Disorders on the AON Advisory Board, with locations in Bethesda and Germantown, Maryland.

He earned his medical degree from the Autonomous University of Guadalajara School of Medicine and completed his internal medicine residency at Kern Medical Center. He later pursued a fellowship in hematology, oncology and bone marrow transplant through the combined UCLA–Veterans Administration Program and the National Cancer Institute at the National Institutes of Health.

Dr. Boccia is a member of the American College of Physicians, the American Society of Clinical Oncology, the American Society of Hematology and the American Society of Blood and Marrow Transplantation. He also serves as a clinical associate professor of medicine at MedStar Georgetown University Hospital, medical director of the International Oncology Network (ION) Clinical Research Program and chair of the ION Medical Advisory Board.

A highly regarded clinician, Dr. Boccia has been consistently recognized for excellence in patient care. He has been listed as a Top Doctor by Washingtonian magazine and Consumers’ Checkbook magazine since 1992 and has been named a Super Doctor by The Washington Post Magazine. He has also been honored as a Regional Top Doctor for Washington, D.C., Baltimore and the Washington–Baltimore region by Castle Connolly.

As radiology medical director and reading radiologist, Dr. McDonald provides expert interpretations for PET and CT imaging for AON partner practices.

He is a board-certified nuclear medicine physician with more than 30 years of experience in diagnostic imaging and radioligand therapies. Prior to his current role at AON, he served as medical director of imaging services for Florida Cancer Specialists & Research Institute, where he specialized in PET/CT interpretation and therapeutic nuclear medicine.

Dr. McDonald has served in key leadership roles at MD Anderson Cancer Center Orlando, worked with Radiology Regional Center in Southwest Florida, and held positions at major medical centers in Oregon and California. He has also held multiple leadership roles within the Society of Nuclear Medicine and Molecular Imaging and is a fellow of the American College of Nuclear Medicine.

An experienced researcher and invited speaker, Dr. McDonald has contributed to numerous clinical studies, publications, and national presentations that have advanced the field of nuclear medicine. He earned his medical degree from the Medical College of Virginia and completed his nuclear medicine residency at the University of California, Irvine Medical Center.

Dr. Praveen Kollipara earned his medical degree from Osmania Medical College in Hyderabad, India. He completed his residency in internal medicine at Coney Island Hospital in Brooklyn, New York, and his fellowship in hematology and oncology at Long Island Jewish Medical Center in New Hyde Park, New York. He is Board certified in medical oncology and hematology.

Dr. Kollipara joined Fort Wayne Medical Oncology and Hematology in 1997. Over the course of his distinguished medical career, spanning two countries, he has become known for blending his extensive professional experience with genuine care and concern for his patients.

Ashley serves as Vice President, Controller at American Oncology Network, where she oversees the organization’s accounting function, financial reporting, regulatory compliance, equity management, and strategic financial planning.

She brings more than 15 years of experience to her role, with the majority spent in the healthcare sector. Her background includes leadership roles in private, equity-backed, and publicly traded companies.

Ashley leads AON’s audits, assists with budget management, and works closely with both executive leadership and internal/external stakeholders to provide data-driven financial insights that support long-term strategic goals. She has a strong command of GAAP, internal controls, tax regulations, and regulatory reporting requirements specific to the healthcare industry.

Ashley holds a Bachelor of Business Administration in Accounting from Georgia State University and has successfully passed the Certified Public Accountant exam. She is committed to advancing patient-centered care through sound fiscal stewardship and responsible resource allocation.

Dave serves as Vice President of Pharmacy, leading AON’s medically integrated specialty pharmacy.  With more than 28 years of pharmacy management experience, he is dedicated to providing patients with the highest levels of pharmacy care in a professional, compassionate manner.

Since joining AON Pharmacy in 2021, he has implemented several strategies to enhance the pharmacy’s dispensing and distribution team, financial patient advocate teams, and compliance and accreditation operations. He and his teams embrace AON Pharmacy’s philosophy of continuous quality improvement, eliminating barriers to medication access, and ensuring patients and clinics consistently receive superior service.

Dave earned his pharmacy degree from Nova Southeastern University in Fort Lauderdale, Florida, and is licensed to practice in 20 states. He works onsite at American Oncology Network’s corporate office in Fort Myers, where the medically integrated specialty pharmacy is located. He and his wife have three children—twin sons and a daughter—all currently working in the oncology field.

As the Chief Growth and Performance Officer at AON, Joe leads growth strategy and performance optimization for AON partner practices, focusing on expansion and new business line opportunities for continued practice growth.

Before joining AON, he served as President of the West Division at Unified Women’s Healthcare, where he oversaw growth, strategy, and operations for more than 200 physicians and served on multiple physician practice and MSO boards. Prior to that, he held several other senior leadership roles at Unified, including Senior Vice President of Financial Operations and Strategy and Vice President of M&A and Corporate Development, playing a key role in national expansion efforts.

Earlier in his career, Joe was an investment banker at global firms such as Jefferies and Rothschild & Co., specializing in healthcare and physician services M&A.

Joe holds Bachelor of Science degrees in finance and accountancy and a Master of Science in accountancy from Villanova University.

As Vice President of IT Operations at AON, William “Billy” is responsible for leading enterprise-wide technology operations, infrastructure management, and IT service delivery. He oversees the development and execution of strategic initiatives that enhance system performance, improve operational efficiency, and ensure secure, scalable technology platforms that support clinical operations and business growth.

With more than a decade of progressive experience in healthcare IT, Billy focuses on aligning technology with organizational priorities. He has successfully led infrastructure modernization efforts, implemented enterprise support models, and built cross-functional teams that deliver measurable impact across the network. His leadership style is rooted in collaboration, continuous improvement, and a commitment to excellence in service delivery.

Billy holds a Bachelor of Arts from Southern New Hampshire University and is a proud United States Air Force veteran. His background in both military and civilian sectors has shaped a results-driven approach grounded in integrity, accountability, and innovation.

As the Chief Human Resources Officer at AON, Terri partners with leaders across the company to create a culture where top talent joins – and stays. With a unique background in human resources, employment law, and healthcare, Terri brings a strategic and multidisciplinary perspective to leadership and talent development.

Before joining AON, Terri served as counsel at Barbas Cremer, a boutique employment law firm, advising clients—particularly in the healthcare sector—on a wide range of employment matters. During her tenure, she also took on interim CHRO roles for several healthcare organizations, including AON. Beginning her career in HR, Terri held executive leadership positions in physician specialty practices, including orthopedics, rehabilitation, aesthetics, and mental health. Her expertise lies in building strong workplace cultures that align with business goals and support long-term growth.

Terri holds both a Bachelor of Science and a Master of Science from Virginia Commonwealth University. After 15 years in HR leadership, she earned her Juris Doctor from John Marshall Law School and was admitted to the Georgia Bar in 2007.

When she’s not working, you’ll find Terri in the kitchen, in the garden, or on a hiking trail with her husband and their dog, Boo.

As General Counsel for AON, Charlie provides strategic guidance to the company’s Executive Team, Board of Directors, business partners, and many other stakeholders in AON’s expanding network of community oncology practices. A trusted advisor known for his actionable insights and dedication to excellence, he oversees AON’s legal department, bringing significant expertise in healthcare law, corporate governance, and compliance.

Charlie’s practice spans a range of complex legal and regulatory domains, including fraud and abuse prevention, data privacy and cyber security, dispute resolution, and the negotiation and execution of high-stakes commercial transactions.

With more than 15 years of legal experience – including positions at an AmLaw 100 firm and as general counsel for a prominent orthopedic surgery group – he is recognized for effectively solving complex challenges through a collaborative and pragmatic approach. His proven ability to align legal strategy with business goals positions him as a trusted resource in navigating the intricacies of healthcare law, regulatory compliance, and organizational governance.

A graduate of the Florida State University College of Law, Charlie is licensed to practice in all Florida state courts and the U.S. District Court for the Middle District of Florida.

Before pursuing a legal career, he toured nationally and internationally as a guitarist with Grammy-nominated and Dove Award-winning artists. This multifaceted background continues to shape his problem-solving approach, blending analytical precision with creativity and empathy.

Outside of his professional endeavors, Charlie is dedicated to his family and personal interests. He enjoys spending time with his wife and two children, and pursuing hobbies including fitness, carpentry, skiing, and cooking.

As vice president of human resources, Karen brings more than 20 years of expertise in HR operations within healthcare organizations. She oversees HR strategy, including employee engagement and leadership development, and serves as a strategic partner, collaborator, and mentor. She is passionate about finding solutions that enhance the organization’s culture and is responsible for developing HR initiatives to integrate new practices into AON.

Karen’s previous roles include HR director for Florida Cancer Specialists and Research Institute and HR manager for Laboratory Corporation of America. She is committed to creating a workplace where employees feel valued and empowered.

Originally from Pennsylvania, Karen earned a degree in psychology from Mansfield University and holds the SPHR designation. She enjoys hiking, biking, and taking advantage of Florida’s warm weather.

Dr. Puneeth Indurlal is a physician leader and passionate advocate for value-based oncology care and healthcare transformation. With over a decade of experience spanning oncology, healthcare operations, and population health, he has led innovative initiatives that align clinical excellence with cost-effective, patient-centered outcomes.

Dr. Indurlal currently serves as Executive Vice President of Strategic Operations & Enterprise Solutions at American Oncology Network (AON), where he oversees enterprise-wide strategic execution, operational performance, and care transformation initiatives across a national network of oncology practices. In this role, he drives the integration of value-based care models, data-driven decision-making, and scalable operational frameworks to enhance quality, access, and affordability in cancer care delivery.

Prior to joining AON, Dr. Indurlal held leadership roles within The US Oncology Network, Illinois Cancer Specialists, and Fox Valley Hematology Oncology, where he led efforts in medical management, practice optimization, quality improvement, and alternative payment models.

An active contributor to oncology research and thought leadership, Dr. Indurlal has presented at leading national forums including ASCO, AVBCC, COA, and NCCN, with published materials in journals such as the Journal of Clinical Oncology (JCO), Journal of the American Pharmacists Association (JAPhA), Journal of Clinical Pathways (JCP), and Journal of the National Comprehensive Cancer Network (JNCCN). As a speaker, he frequently shares insights on value-based care, provider strategy, practice management, and innovative models of care delivery.

David serves as the Chief Financial & Operating Officer (CFO and COO) and brings over 25 years of private equity-backed and public company experience in high growth environments to AON’s executive team. His extensive financial, revenue cycle and operating experience spans companies across various healthcare services sectors, including pediatric and adult home health, long-term acute care and multi-specialty physician practices. David’s background includes significant M&A, integrations, capital markets and initial public offering experience across the companies he has served.

Prior to joining AON, he served as CFO for U.S. Heart and Vascular, Aveanna Healthcare, and ApolloMD. He also held leadership positions at the Public Company Accounting Oversight Board, Regency Hospital Company and EY.

David graduated magna cum laude with a Bachelor of Science in Accounting from the University of Maryland. He then passed the CPA exam, scoring among the top 10 in Maryland and a high score nationally. His achievements were acknowledged in 2023 when he was ranked No. 9 in the “Top 25 CFOs of Georgia” by Finance & Investing magazine.

Bill has served on various boards including Fresenius Medical Care AG Management Board, Fresenius Medical Care Holdings, Inc., Sound Physicians, Interwell Health and Vifor FMC Renal Pharma, Ltd. From 2017 to 2023, he served as chief executive officer of FMC North America and then chief executive officer of global care delivery at Fresenius Medical Care AG. Before that, Bill spent seven years at Fresenius Medical Care Holdings, Inc., having served as president of Fresenius Kidney Care and having held leadership positions in Azura Vascular Care, business development, real estate/construction services, renal integrated strategies, Fresenius Rx and Spectra Laboratories. His other career experience includes a seven-year tenure at Innovative Health Strategies, LLC.; twelve years at Gambro Healthcare, Inc.; and positions at Gambro Healthcare, Inc.; CD Medical, Inc.; and Analytab Products, Inc.

As vice president of mergers and acquisitions (M&A), Kyle is responsible for identifying and developing new partnerships with physicians and health systems. He brings over 12 years of experience in corporate finance, strategy and consulting related to physician practices.

Before joining AON, Kyle held leadership roles at Sound Physicians, a national inpatient physician practice management organization. At the end of a six-year tenure focused on M&A and growth initiatives at Sound Physicians, he played a key role in developing and managing the organization’s first accountable care organization, which saved Medicare nearly $114 million in total shared savings in only its second year of performance.

Kyle began his career in healthcare investment banking and healthcare consulting with various firms in Nashville, Tennessee. He holds an MBA from Vanderbilt University and a bachelor’s degree in accounting and corporate finance from East Tennessee State University.

Bradley has served on the DTOC Board since DTOC’s IPO. He currently advises a number of technology-enabled healthcare companies. From October 2012 to January 2018, he was the Senior Vice President, Chief Healthcare Commercial Market Development Officer and Chief Strategy and Business Development Officer for the Walgreens Company. Prior to Walgreens, Bradley served as an executive in residence at Health Evolution Partners from April 2011 to September 2012, Executive Vice President and Chief Strategy and External Affairs Officer of Anthem Inc. from October 2007 to December 2010, Senior Vice President of National Accounts and Vice President of Enterprise Strategy at Aetna Inc. from March 2005 to September 2007, and Chief Executive Officer for Reden & Anders (Optum Consulting) from October 2002 to February 2005. Bradley currently serves on the board of directors of MJHS in New York City, Performant Financial Corporation, and Premera Blue Cross, among others. He earned a MPP from Harvard University’s Kennedy School of Government and a BBA from the University of Washington. Bradley also serves as a lecturer at the University of Pennsylvania’s Wharton School of Business.

Ravi is Co-Head and Founding Partner of AEA Growth since 2021. He is also the Founder and Managing Partner of ROCA Partners, a growth equity investment firm focused on tech-enabled services, software and healthcare services companies, which he founded in 2015. Previously, he was a principal in the private equity group at Ares Management from 2009 to 2015. Prior to Ares, Ravi was a private equity investor at Bain Capital and a consultant at Bain & Company. He currently serves on the board of directors of several companies including AS Software, Bespoke Partners, Cenegenics, Commonwealth Pain & Spine and Mark Spain Real Estate and previously served on the board of directors of a number of companies including Floor & Decor, Jacuzzi Brands, Ob Hospitalist Group, Oceans Healthcare, Riviera Partners, The Oncology Institute, True Blue Car Wash and Unified Women’s Healthcare. Ravi received a B.S. in Electrical Engineering and a M.S. in Management Science and Engineering from Stanford University and an M.B.A. from Harvard Business School.

.

Alti serves as the chief strategy and innovation officer and is responsible for establishing and reviewing strategic priorities and monitoring the execution of the plans.

He holds a dual Master of Business and Healthcare Administration degree and is a Certified Six Sigma Black Belt.

Alti is proud of his South Asian heritage and has fond memories of his childhood when he lived in the Middle East in the small country of Kuwait. His career in healthcare started as a mental health case worker, which shaped his career in healthcare administration where he felt there was a tremendous gap between medical interventions and the pursuit of public health goals.

Prior to joining AON, Alti spent 15 years at Oncology Consultants in Houston, Texas, a successful community oncology practice. In this role, he pursued value-based care and continuous operational, cost and quality improvements.

Alti believes that the future of healthcare involves a multidisciplinary and unapologetically collaborative approach, keeping the patient at the center of all decisions.

Susan is the vice president of clinical innovation at AON and oversees the clinical programming function that includes care plan design, care program implementation and monitoring, and clinical integration with payers and providers.

She has over 25 years of experience in healthcare. Previously, she was the executive director of clinical strategy at Oncology Consultants in Houston, Texas, where she developed and implemented innovative clinical strategies and policies that led to the growth of the company. Susan has created clinical and operations protocols for all levels of practice to promote value-based care initiatives in both commercial and non-commercial payer populations. She has established an appropriate framework and oversight, including input into growth, strategy, resourcing, and decision-making to innovate around consumer-focused oncology programs. Developing a community-based oncology navigation program and collaborating to implement a fully integrated initiative to address social determinants of health within the practice has been significant in her role.

Susan currently sits on the COA Administrators Network Board (CAN), the COA Patient Advocacy Network (CPAN) Advisory Panel and the Houston Cancer Health Equity Collaborative. She is an advisor to the Health Equity & Access Committee for the Texas Society of Clinical Oncology (TxSCO) and sits on the COA Health Equity Committee.

Susan holds a Bachelor of Science in Nursing from the University of Pittsburgh and a Master of Science in Nursing Administration from the University of Texas at Arlington. Additionally, she has the Nurse Executive Advanced Certification and has held the Oncology Nurse Certification for 16 years.

James is a partner of AEA Growth and a member of the AEA Growth Investment Committee. Prior to AEA Growth, James was a co-founder and partner of ROCA Partners, a growth equity investment firm focused on tech-enabled services and healthcare services companies. Previously, he served as an M&A executive at IAC/InterActiveCorp, a private equity investor at Ares Management and an investment banker at Lehman Brothers. James has a bachelor’s degree in economics and international relations from the University of Pennsylvania.

Dr. Olson serves as medical director of AON’s pathology laboratory. Prior to joining AON, he worked at Florida Cancer Specialists & Research Institute as a staff hematopathologist for 12 years and as the laboratory medical director for eight.

Dr. Olson received his medical degree from Albany Medical College (AMC) in Albany, New York, and completed a residency at the University of California San Diego and AMC. His training continued with a fellowship in surgical pathology and hematopathology at AMC. Dr. Olson is Board certified in anatomic pathology, clinical pathology and hematopathology.

With more than 30 years of healthcare experience Todd serves AON as Chief Executive Officer and is a Board Member on the Board of Directors. Todd is responsible for overseeing AON’s mission, strategy, operations and finances. As President & Chief Operating Officer of AON since its inception in 2017 to 2021, he made significant contributions across practice operations, central ancillaries, information technology and strategy.

In his role as Florida Cancer Specialists (FCS) Chief Operating Officer, he was responsible for the day-to-day operations within the corporate office and nearly 100 locations throughout Florida. Prior to his role as COO of FCS in 2011, Todd was Senior Vice President and Chief Information Officer for US Oncology. As part of the senior management team, Todd helped set organizational goals and objectives, oversaw strategic project prioritization, and led tactical execution of company-wide initiatives. He was also responsible for all day-to-day operational aspects of information technology and strategic direction for the information technology needs of the organization. While Senior Vice President and Chief Information Officer, he was named to the Information Week 500 and received the ComputerWorld/IDG Laureate Award, recognizing individuals and organizations that use information technology to benefit society. During his tenure at US Oncology, he also held positions as the Director of Enterprise Applications and Vice President of Information Systems. Todd’s consulting and management experience in healthcare information technology includes positions with Datamedic Corporation (acquired by VitalWorks and later Amicas Corporation), Multum Corporation (acquired by Cerner Corporation), and MedE America (acquired by WebMD and later HLTH Corporation).

Todd received a bachelor’s degree in health policy and administration from Pennsylvania State University. Todd has presented at national industry conferences including multiple Community Oncology Alliance (COA) conferences as well as national and regional information technology conferences. Additionally, Ernst & Young LLP named Todd an Entrepreneur Of The Year® 2023 Florida Award finalist. Entrepreneur Of The Year celebrates ambitious entrepreneurs who are building bolder futures.

As chief medical officer, Dr. Divers plays a vital role in advancing AON’s mission by providing leadership, strategy and vision for practice transformation. He ensures that AON’s clinical model continues to evolve to meet the needs of patients and the communities the network serves.

Dr. Divers is a medical oncologist with Genesis Cancer and Blood Institute, one of the first practices to join the AON network in summer 2018.

A respected physician leader, Dr. Divers has served on several national committees and currently sits on the Board of Directors for the Community Oncology Alliance (COA). He earned his medical degree from the Louisiana State University School of Medicine, completed his residency at the University of North Carolina, and went on to complete a fellowship at the University of Alabama at Birmingham Cancer Center.

In addition to his role as CMO, Dr. Divers serves as AON advisory board chairman and vice chairman of the Board of Directors, while continuing to care for patients at Genesis Cancer and Blood Institute.

Anthony serves as AON’s Chief Development Officer, beginning in late 2022. He brings with him more than 20 years of experience in company growth, development and leadership.

Anthony joins AON after serving as LifePoint Health’s Vice President of In-Market Development. In his role, he drove acquisitions, joint ventures and other strategic initiatives to diversify the company’s services for its 65 acute care hospitals in 28 states. Prior to that, he was the Chief Development Officer at CleanSlate Centers, Inc. and was responsible for managing the expansion of the company’s footprint of outpatient addiction clinics, growing the platform from 14 centers in two states to 80 centers in 10 states during a four-year period.

Anthony also has served as the Senior Vice President of Business Development for DSI Renal (now U.S. Renal Care), Vice President of Business Development for U.S. HealthWorks (now Concentra), and Executive Vice President of Liberty Dialysis (now Fresenius Medical Care).

He has a background in investment banking and received his MBA with a concentration in finance from UCLA’s Anderson School of Management. He obtained his bachelor’s degree in economics from The Wharton School at the University of Pennsylvania.

Karen serves as Chief Revenue Cycle Officer at AON where she has oversight of the AON revenue cycle health, supports the development of end-to-end revenue cycle services, utilization management, payer contracting and government and managed care payer regulation and compliance.

Karen joined AON in June of 2022 and brings a proven background in healthcare revenue cycle for organizations like US Oncology, Cancer Treatment Centers of America and MAP Health Management. She was previously Chief Strategy Officer of Value-Based RCM responsible for implementing significant growth in the revenue cycle management business, including potential acquisitions of other billing companies and growth outside the behavioral health vertical.

Karen is an industry veteran with more than 40 years of experience in the areas of healthcare billing/collection, revenue cycle management, and government and managed care payer regulation and compliance. She has held positions with Virtual Radiology, a network of onsite and teleradiology physicians; SPI Healthcare, one of the largest global revenue cycle management organizations with more than 500 employees located in Chicago and Manila; and US Oncology, as the Vice President of Reimbursement Services for 13 years.

Karen holds a Bachelor of Science in Nursing from Lewis A. Wilson School of Nursing.

As chief medical officer, Dr. Divers plays a vital role in advancing AON’s mission by providing leadership, strategy and vision for practice transformation. He ensures that AON’s clinical model continues to evolve to meet the needs of patients and the communities the network serves.

Dr. Divers is a medical oncologist with Genesis Cancer and Blood Institute, one of the first practices to join the AON network in summer 2018.

A respected physician leader, Dr. Divers has served on several national committees and currently sits on the Board of Directors for the Community Oncology Alliance (COA). He earned his medical degree from the Louisiana State University School of Medicine, completed his residency at the University of North Carolina, and went on to complete a fellowship at the University of Alabama at Birmingham Cancer Center.

In addition to his role as CMO, Dr. Divers serves as AON advisory board chairman and vice chairman of the Board of Directors, while continuing to care for patients at Genesis Cancer and Blood Institute.

Erica is a healthcare-specialized attorney with nearly a decade of transactional and regulatory experience. She is one of less than 130 attorneys in Florida to be Board certified in Health Law by The Florida Bar. Prior to joining AON, Erica most recently served as in-house counsel at Greenway Health, an electronic health record vendor. During her time at Greenway, she focused on vendor management, strategic relationships, and compliance with healthcare regulations. Erica was instrumental in the negotiation, implementation, and ongoing compliance with Greenway’s Corporate Integrity Agreement. Prior to her tenure at Greenway, Erica worked as an attorney in the healthcare group of Carlton Fields, P.A., and previously served as in-house counsel at The Children’s Hospital of Philadelphia, one of the top children’s hospitals in the nation.

Erica is passionate about volunteerism and is particularly dedicated to her role on the Board of Directors of the Children’s Cancer Center, a Tampa-based non-profit that provides emotional, financial, and educational support to more than 1,000 children with cancer or life-threatening blood disorders and their families.

Erica holds a Bachelor of Science degree in Journalism with dual minors in Business and Political Science from Ohio University and a law degree from Drexel University.

James serves as Chief Pharmacy & Clinical Services Officer at AON. James joined AON in July of 2021 bringing close to 30 years of experience in both clinical and community oncology industry leadership roles.

Prior to joining AON, James served as Executive Vice President at Georgia Cancer Specialists in Atlanta, overseeing clinical, pharmacy, research, and imaging operations, as well as financial and strategic planning for 26 outpatient oncology clinics and two retail pharmacies and managing over 500 employees.

After earning his PharmD degree from Mercer University Southern School of Pharmacy, James received advanced clinical training from Georgia Baptist Medical Center in Atlanta. He began his career as a clinical pharmacist then transitioned into oncology program administration, as well as managing large clinical research and data mining programs.

Heavily involved in national oncology and pharmacy organizations, James is a member of the American Society of Clinical Oncology, Georgia Society of Clinical Oncology, National Community Oncology Dispensing Association, Inc.’s (NCODA) Executive Counsel, ION’s SON Advisory Panel and Precision Medicine Advisory Panel, and is a member of the American College of Healthcare Executives. He is a reviewer for Community Oncology and Advances in Therapy, and has co-authored over 65 published articles, abstracts, and book chapters.

Guy leads AON’s radiation and radiology services. With more than 25 years’ experience Guy has served in a variety of roles gaining a deep understanding of how today’s healthcare is delivered particularly within the diagnostic imaging space.

Prior to joining AON Guy served as Chief Executive Officer of Trident Medical Imaging, a multi-modality diagnostic imaging organization with a primary focus on PET/CT and oncologic imaging. During his tenure at Trident, Guy also served as Chief Financial Officer and Vice President of Sales. In addition, Guy served on the Technical Assessment Committee for Georgia’s Department of Community Health tasked with developing the state’s Certificate of Need Rules for PET/CT scanners and volunteered his services as Chief Financial Officer for the non-profit Outpatient Imaging Coalition.

Guy has been instrumental in developing imaging centers throughout the U.S and his career includes sales management positions with CTI, Siemens, and CYTOGEN. He has served as Director of Nuclear Medicine with a multi-specialty facility and has been published as principal author of peer-reviewed journal articles. He also served as Adjunct Faculty with George Washington University’s Nuclear Medicine Technology program while simultaneously teaching at the US Navy’s Clinical Nuclear Medicine School as Senior Instructor.

Guy received his MBA from Georgia State University and his Bachelor of Science in Health Care Management from Southern Illinois University.

Katie oversees AON’s current and future clinical research initiatives. She is passionate about bringing scientific innovation and clinical trial access to the community setting where most oncology patients will receive their care.

Katie has over 25 years of healthcare experience including oncology nursing, clinical research, and program development. After graduating from Florida State University with her Bachelor of Science in Nursing, Katie worked in Atlanta at Emory Hospital where she cared for critically ill patients in medical and surgical critical care units. For the last 19 years, Katie worked at Florida Cancer Specialists & Research Institute in Sarasota, Fla. While there, she developed processes which supported a network of 37 community-based clinical research sites throughout Florida, enrolling over 500 patients annually to phase 1-3 protocols. During her tenure she was responsible for many initiatives including opening two fully dedicated phase 1 clinical trial units and implementing technology solutions used to successfully match patients to clinical trials using clinical and genomic data.

Melody oversees AON’s pharmacy operations, establishes guidelines and standard operating procedures, develops drug utilization and formulary initiatives ensuring cost-effectiveness and optimized therapeutic outcomes. She gives guidance on IV room design and keeps abreast of industry standards to ensure the pharmacy is in compliance with USP 797/USP 800 and state/federal regulatory requirements.

Melody has over 20 years of clinical and management experience in pharmacy. Prior to her role as Vice President of Pharmacy Operations, she was the Director of Pharmacy Operations for Florida Cancer Specialists & Research Institute (FCS) for seven years. She established the pharmacy operational program, drafted the pharmacy training manual, and instituted the regional trainer program that enabled a standard practice throughout nearly 100 FCS locations. Prior to FCS, Melody worked as a lead pediatric oncology pharmacist at Lee Health in Florida, and as an oncology pharmacist at MD Anderson Cancer Center Orlando (now UF Health Cancer Center).

Melody received her Bachelor of Science in Pharmacy from China Medical University in Taiwan and earned her MBA degree from Tulane University in New Orleans. She is a Board-Certified Oncology Pharmacist and has served as a Pharmacist Liaison to the Florida Society of Clinical Oncology (FLASCO) Board of Directors since 2017. She also sits on the Association of Community Cancer Center (ACCC) Oncology Pharmacy Education Network Advisory Committee.

As Vice President of Finance, Michael oversees the analytical support provided to all levels of management throughout the organization. In addition to heading up the analysis of existing operations, Michael works with prospective AON partner physicians to facilitate the transition from individual and group practice to affiliation with AON. His over 20 years of prior experience includes progressive financial roles with McKesson and Cardinal Health, the Timken Company, the acquisition and management of charter schools throughout the southeastern U.S., and, most recently, Florida Cancer Specialists & Research Institute.

Originally from Ohio, Michael earned his bachelor’s degrees in finance, business and education from Walsh University and his MBA from Ashland University. He is also certified as a Six Sigma Green Belt.

Caroline leads marketing and communications strategies for AON corporate and its partner practices to strengthen brand and support the organization’s long-term growth initiatives. With over 17 years of successful marketing management and leadership experience, she is a data-driven and creative marketer, having achieved excellent results driving demand generation and business growth. Since joining AON in July 2019, she has devised and implemented numerous impactful external and internal initiatives and campaigns. She was instrumental in the creation of the organization’s refreshed brand strategy and website, launched in 2020. Prior to joining AON, she managed the strategic direction of the marketing plan for Harmony Healthcare, oversaw the brand, product and content marketing for Spectrum Enterprise, and online marketing for Greenway Health.

Caroline holds a Bachelor of Arts in Japanese Studies from the University of London and earned her Masters in Business Administration from Durham University, England. Caroline is proud of her British and Asian heritage and has lived in many different countries including Thailand, Japan, Hong Kong, Cyprus, the Philippines and England.

Tena oversees clinical operations for AON. Throughout her 30 years of experience in oncology, Tena has learned, honed, and mastered her clinical, operational, leadership and teamwork acumen. Her work as an oncology nurse and nurse practitioner in both inpatient and outpatient settings has cultivated a well-rounded perspective on patient care. She has successfully led multiple quality initiatives and practice certifications including Quality Oncology Practice Initiative (QOPI) with ASCO, CMS Promoting Interoperability, and physician performance initiatives for a hospital-based quality program.

Like many leaders, Tena did not embark on her career with the goal of being a “leader,” rather, she set out simply to make a difference. Tena’s core principle has always been “patients first” and this is the root of her leadership success. The true mettle of a leader may not be seen in normal day to day operations but in crisis. Over the years, Tena has faced crises with poise and grace. As Clinical Operations Director, Tena oversaw the rebuilding of a medical oncology practice following a tragic fire, re-establishing operations within three days. She has led multiple successful negotiations for practice transformations resulting in continued practice growth and expansion of services. Her commitment to quality oncology care led to the development of multiple outpatient care programs including Survivorship, Oncology Triage Clinic, and Palliative Care. The outcome of these positive developments ranged from improved quality of life to reduced hospital admissions for patients.

In 2001, Tena graduated from Duke University School of Nursing with an MSN and an adult medicine nurse practitioner certificate with a sub-specialty in oncology and HIV. She has received multiple awards and honors throughout her career, including the Thelma Ingle Award for Excellence in Clinical Expertise and Scholarly Activities from the Beta Epsilon Chapter of Sigma Theta Tau. In 2018, Tena completed the Clinical Leadership Fellowship through CTI Leadership.

Kristin serves as Chief Compliance & Risk Officer at AON.

An attorney with more than 15 years of health law experience, Kristin has provided guidance to hospitals, health systems and large physician groups on complex compliance and regulatory issues.

Kristin joined AON in August of 2020. Prior to joining AON, Kristin served as Executive Director-Regulatory and Compliance Counsel at Mercy in St. Louis, which was named one of the top five large U.S. health systems for four consecutive years (2016 to 2019) by IBM Watson Health. During her tenure at Mercy, she served as the primary legal advisor for all compliance and regulatory issues throughout the system, including implementation of and compliance with the requirements of the first three years of a Corporate Integrity Agreement.

Prior to joining Mercy, she served as in-house legal counsel for BJC HealthCare in St. Louis, primarily representing its medical group of over 800 employed physicians, and represented large physician groups and hospital systems within the healthcare practice groups of Squire Patton Boggs and Porter and Wright, Morris and Arthur in Columbus, Ohio.

Kristin holds dual Bachelor of Arts degrees in Political Science and History from University of Missouri-Columbia and a law degree from Capital University Law School.

Steve serves as Executive Vice President of Practice Operations for AON. Steve most recently served as executive director for the Zangmeister Cancer Center. Prior to that, he held the position of CEO at the Robert C. Byrd Clinic at the West Virginia School of Osteopathic Medicine in Lewisburg, W. Va., CEO and CFO of University Medical Associates, Inc. in Athens, Ohio, and President and CEO of OhioHealth Doctors Hospital in Nelsonville, Ohio.

Steve attended Ohio University, where he earned his Bachelor of Applied Arts degree in accounting and pre-law.

Dr. Daniel Spitz graduated from medical school at the Medical University of South Carolina, located in Charleston, S.C. and was awarded a Fellowship in Oncology/Hematology at the Bellevue Medical Center located in New York, N.Y. He is Board certified in medical oncology, hematology and internal medicine. Dr. Spitz served on the Board of Directors for the Palm Beach County Chapter of the American Cancer Society and on the National Medical Advisory Board of the National Ovarian Cancer Coalition of Palm Beach.

Mark is responsible for overseeing AON’s information technology (IT) and serves as a member of the MiBA (Meaningful Insights Biotech Analytics) leadership team, which is a cutting-edge data source for cancer research, clinical trial matching, pharma utilization and new drug development.

He specializes in envisioning and managing technology-based solutions that support the ongoing improvement and continuity of high-quality patient care as well as bringing top-of-line innovative technology knowledge to help with the advancements in precision oncology. Mark played a pivotal role at AON by building the IT infrastructure that positioned the company for fast growth and its transition to going public in September 2023. He is a recipient of the CIO of the Year award in the corporate sector of the 2023 CIO of the Year ORBIE Awards, which is hosted by SouthFloridaCIO.

Prior to joining AON, Mark served as chief information officer for Florida Cancer Specialists & Research Institute. He also served as vice president of information technology at Promise Healthcare, Inc., the nation’s fifth-largest long-term acute care (LTAC) hospital company, where he was responsible for the leadership and planning of information technology for all the Promise Healthcare locations.

A native of Poland, Mark began his career as a teacher of literature and holds a Master of Arts degree in Polish Philosophy from the University of Wroclaw in Poland. After moving to the United States, he entered the IT field and transitioned to healthcare IT where he quickly embraced the impact technology would have on healthcare operations and patient care.

With more than 30 years of healthcare experience Todd serves AON as Chief Executive Officer and is a Board Member on the Board of Directors. Todd is responsible for overseeing AON’s mission, strategy, operations and finances. As President & Chief Operating Officer of AON since its inception in 2017 to 2021, he made significant contributions across practice operations, central ancillaries, information technology and strategy.

In his role as Florida Cancer Specialists (FCS) Chief Operating Officer, he was responsible for the day-to-day operations within the corporate office and nearly 100 locations throughout Florida. Prior to his role as COO of FCS in 2011, Todd was Senior Vice President and Chief Information Officer for US Oncology. As part of the senior management team, Todd helped set organizational goals and objectives, oversaw strategic project prioritization, and led tactical execution of company-wide initiatives. He was also responsible for all day-to-day operational aspects of information technology and strategic direction for the information technology needs of the organization. While Senior Vice President and Chief Information Officer, he was named to the Information Week 500 and received the ComputerWorld/IDG Laureate Award, recognizing individuals and organizations that use information technology to benefit society. During his tenure at US Oncology, he also held positions as the Director of Enterprise Applications and Vice President of Information Systems. Todd’s consulting and management experience in healthcare information technology includes positions with Datamedic Corporation (acquired by VitalWorks and later Amicas Corporation), Multum Corporation (acquired by Cerner Corporation), and MedE America (acquired by WebMD and later HLTH Corporation).

Todd received a bachelor’s degree in health policy and administration from Pennsylvania State University. Todd has presented at national industry conferences including multiple Community Oncology Alliance (COA) conferences as well as national and regional information technology conferences. Additionally, Ernst & Young LLP named Todd an Entrepreneur Of The Year® 2023 Florida Award finalist. Entrepreneur Of The Year celebrates ambitious entrepreneurs who are building bolder futures.